Evidence map›Paper›PMID 36032463›Full record

ArticleAfrican health sciences2022

Circulation of hepatitis B virus genotype-E among outpatients in tertiary hospitals in the Niger-Delta region of Nigeria.

Chinenye F Umego, Clement I Mboto, Atim D Asitok, Linda C Osaji, Uwem E George, Uwem O Edet, Elizabeth N Mbim, Temitope Oc Faleye, Olubusuyi M Adewumi, Johnson A Adeniji

Abstract read
In one paragraph

Article in African health sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chinenye F UmegoDepartment of Microbiology, Faculty of Biological Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Clement I MbotoDepartment of Microbiology, Faculty of Biological Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Atim D AsitokDepartment of Microbiology, Faculty of Biological Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Linda C OsajiDepartment of Microbiology, Faculty of Biological Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Uwem E GeorgeViro-Bio Research Group, Faculty of Biological Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Uwem O EdetViro-Bio Research Group, Faculty of Biological Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Elizabeth N MbimDepartment of Microbiology, Faculty of Biological Sciences, University of Calabar, Calabar, Cross River State, Nigeria.
Temitope Oc FaleyeDepartment of Virology, Faculty of Basic Medical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Olubusuyi M AdewumiDepartment of Virology, Faculty of Basic Medical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Johnson A AdenijiDepartment of Virology, Faculty of Basic Medical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hepatitis B virus (HBV) infection continues to be a significant public health challenge globally, with higher disease burden in developing countries. HBV genotypes are associated with different geographical regions and clinical outcomes. Limited information exists on epidemiology of HBV in the Niger-Delta region (South-South) of Nigeria. Consequently, this study was designed to characterise hepatitis B virus infection among outpatients in selected tertiary hospitals in the region. Methodology: Between June and August 2017, consenting nine hundred asymptomatic out-patients were enrolled and initially screened for HBV infection using one step Hepatitis B surface antigen (HBsAg) strip and subsequently re-tested using HBsAg and Hepatitis B core total antibody (anti-HBc) specific Enzyme-Linked Immunosorbent Assay (ELISA). Blood serum with detectable HBsAg were subsequently subjected to DNA extraction, S-gene amplification using a nested polymerase chain reaction (PCR) protocol, gel electrophoresis, sequencing and phylogenetic analysis. Results: Seroprevalence of HBsAg was 4.6% (95% CI 2.5-7.1) and anti-HBc was 10.1% (95% confidence interval (CI) 6.1-15.3). Of the 41 HBsAg positive samples subjected to DNA extraction and HBV S-gene specific PCR, only 6 (14.6%) yielded the expected ∼408bp band. Phylogenetic analysis based on HBV pre-S/S sequences identified all six typable samples as genotype E, subtype ayw4 of the West African clade. Conclusion: Results of the study confirm the presence and circulation of HBV genotype-E in the Niger-Delta region of Nigeria, thus corroborating the inclusion of the country in the Genotype E crescent. The authors advocate value-added HBV intervention in the region and the country at large.

Indexed as

Hepatitis BHepatitis B virusDNADNA, ViralGenotypeHepatitis B AntibodiesHepatitis B Surface AntigensHumansNigerNigeriaOutpatientsPhylogenySeroepidemiologic StudiesTertiary Care CentersDNADNA, ViralHepatitis B AntibodiesHepatitis B Surface AntigensHBsAgHBVNiger-DeltaNigeriaSouth-South

Identifiers

PMID36032463
PMCPMC9382501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.